TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36343185

Group type: EXPERIMENTAL
Intervention: Various interventions from 13 multicenter RCTs conducted by PCCS-SG; specific interventions not detailed in the abstract.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pilot RCTs as part of the research process; specific details not provided.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collaborative research facilitated by a national registry and partnerships with Clinical Trials Units; specific interventions not detailed.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Involvement of transport teams in trials; specific interventions not detailed.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Funded infrastructure of clinical research staff within the NHS; specific interventions not detailed.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Greater international collaboration and embedded trial platforms; specific interventions not detailed.
Number of subjects: 0
Study: 34981467

Group type: EXPERIMENTAL
Intervention: Curcuminoids (500 mg/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 33762239

Group type: EXPERIMENTAL
Intervention: Explanatory model without personalisation (intervention group 1, n=25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Explanatory model with elements of personalisation (intervention group 2, n=25)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group receiving information on current PSS guidelines (n=25)
Number of subjects: 75
Study: 34818646

Group type: EXPERIMENTAL
Intervention: Lullaby intervention (listening to lullabies for 20 min once a day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no lullaby intervention)
Number of subjects: 76
Study: 33258033

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 158
Study: 35331684

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (500 μg)
Number of subjects: 2040

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 2040
Study: 33915192

Group type: EXPERIMENTAL
Intervention: TAP block
Number of subjects: 45

Group type: COMPARATOR
Intervention: Epidural technique
Number of subjects: 45
Study: 33616190

Group type: EXPERIMENTAL
Intervention: 5-session psychological intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: treatment-as-usual control group
Number of subjects: 60
Study: 32961385

Group type: EXPERIMENTAL
Intervention: CycleGAN (deep learning-based domain transfer from UWFP to TFP)
Number of subjects: 1196
Study: 33587549

Group type: EXPERIMENTAL
Intervention: mIER (4 × 3 wk of moderate energy restriction interspersed with 3 × 1 wk of energy balance)
Number of subjects: 61

Group type: COMPARATOR
Intervention: mCER (12 wk of continuous moderate energy restriction)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: mIER
Number of subjects: 61

Group type: COMPARATOR
Intervention: mCER
Number of subjects: 61
Study: 36068183

Group type: EXPERIMENTAL
Intervention: Needle bevel pointing downwards during insertion
Number of subjects: 35

Group type: COMPARATOR
Intervention: Needle bevel pointing upwards during insertion
Number of subjects: 35
Study: 33751659

Group type: EXPERIMENTAL
Intervention: Bayesian additive regression trees (BART) with mixed models
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mixedBART framework
Number of subjects: 0
Study: 35534039

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Erdosteine
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Azithromycin and/or Erdosteine
Number of subjects: 104
Study: 33472541

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Various treatment effect estimation methods
Number of subjects: 0
Study: 35982457

Group type: EXPERIMENTAL
Intervention: Dental Care Professionals (dental therapists and dental nurses) visiting care homes every 6 months and monthly for the first 3 months, then three-monthly thereafter
Number of subjects: 280

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 280
Study: 34639644

Group type: EXPERIMENTAL
Intervention: WAT-based group exercise intervention for 14 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group with similar physical training and all BCTs
Number of subjects: 40
Study: 36477479

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention delivered on a web-based platform
Number of subjects: 4118

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 4118
Study: 34737364

Group type: COMPARATOR
Intervention: 5-hydroxytryptophan (5-HTP) supplementation
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Tryptophan (TRP) enriched diet
Number of subjects: 77
Study: 32199123

Group type: COMPARATOR
Intervention: FBH+
Number of subjects: 69176

Group type: EXPERIMENTAL
Intervention: FPH
Number of subjects: 69176
Study: 33855814

Group type: EXPERIMENTAL
Intervention: Pneumatic retinopexy (PnR)
Number of subjects: 0
Study: 33896224

Group type: EXPERIMENTAL
Intervention: Somatropin treatment
Number of subjects: 20890

Group type: COMPARATOR
Intervention: Non-GHD controls
Number of subjects: 20890

Group type: EXPERIMENTAL
Intervention: Treated GHD patients
Number of subjects: 20890
Study: 32684325

Group type: EXPERIMENTAL
Intervention: Non-elastic taping
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo-taping
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between non-elastic taping and placebo-taping
Number of subjects: 30
Study: 34281849

Group type: EXPERIMENTAL
Intervention: Low-dose OSK-0028 (0.25 μg/kg/h)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: High-dose OSK-0028 (0.5 μg/kg/h)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: OSK-0028 (both doses)
Number of subjects: 75
Study: 35200094

Group type: EXPERIMENTAL
Intervention: R3 (3 minutes of active recovery)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: R1 (1 minute of active recovery)
Number of subjects: 30
Study: 34498248

Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32178811

Group type: EXPERIMENTAL
Intervention: High Stress/Low Coping
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Low Stress/High Coping
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Profiles overall
Number of subjects: 102
Study: 36011519

Group type: EXPERIMENTAL
Intervention: Telemedicine‐delivered counseling and printed materials on diet and medication adherence
Number of subjects: 299

Group type: COMPARATOR
Intervention: Control group (counseling on smoking and physical activity)
Number of subjects: 299
Study: 33243231

Group type: EXPERIMENTAL
Intervention: Cross‐curricular nutrition and mathematics program (4–5 lessons over 1–4 weeks)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Teaching quality assessment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Process evaluation using teacher interviews and student focus groups
Number of subjects: 12
Study: 34332557

Group type: COMPARATOR
Intervention: Gefitinib 250 mg/day monotherapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination therapy with allogeneic CD8 + CD56+ NKT cell infusions twice per month for 12 cycles
Number of subjects: 30
Study: 32228462

Group type: EXPERIMENTAL
Intervention: Couple-based intervention arm (patients and spouses receive four-weekly structured group education & training sessions and 2 months of weekly tailored behavior change boosters)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Individual-based control arm (only patients receive the interventions)
Number of subjects: 194
Study: 34321338

Group type: EXPERIMENTAL
Intervention: Loss-frame reminders
Number of subjects: 22046

Group type: EXPERIMENTAL
Intervention: Gain-frame reminders
Number of subjects: 22046

Group type: EXPERIMENTAL
Intervention: Precommitment messages
Number of subjects: 22046

Group type: EXPERIMENTAL
Intervention: Reminder for second vaccination
Number of subjects: 22046

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22046
Study: 33778831

Group type: EXPERIMENTAL
Intervention: Pulp revascularization
Number of subjects: 100

Group type: COMPARATOR
Intervention: Apexification
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 35906331

Group type: EXPERIMENTAL
Intervention: Higher-density formula (HDF, 90 kcal/100 ml)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard-density formula (SDF, 67 kcal/100 ml)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Higher-density formula (HDF)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard-density formula (SDF)
Number of subjects: 64
Study: 32677455

Group type: EXPERIMENTAL
Intervention: Relaxation-focused nursing care
Number of subjects: 66
Study: 32672570

Group type: EXPERIMENTAL
Intervention: Amniotic membrane‐umbilical cord (AM‐UC)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Pericardium patch grafts
Number of subjects: 81
Study: 33040236

Group type: EXPERIMENTAL
Intervention: Lichtenstein technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: ONSTEP technique
Number of subjects: 40
Study: 32268801

Group type: EXPERIMENTAL
Intervention: Heparin plus exercise
Number of subjects: 32

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 32
Study: 35906459

Group type: EXPERIMENTAL
Intervention: LA-NOSE (using Cai tube)
Number of subjects: 60
Study: 35612866

Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg or 2.5 mg twice daily)
Number of subjects: 4581

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 4581

Group type: COMPARATOR
Intervention: Vitamin K antagonists (VKA)
Number of subjects: 4581

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4581
Study: 36090717

Group type: EXPERIMENTAL
Intervention: Tropocollagen gel applied to the skin around the wound
Number of subjects: 97
Study: 32240018

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) supplementation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sodium chloride (NaCl) as a placebo
Number of subjects: 11
Study: 36170500

Group type: EXPERIMENTAL
Intervention: Bionic pancreas treatment with insulin aspart or insulin lispro
Number of subjects: 326

Group type: COMPARATOR
Intervention: Standard care (any insulin-delivery method with unblinded, real-time continuous glucose monitoring)
Number of subjects: 326
Study: 34570405

Group type: EXPERIMENTAL
Intervention: Befriending by volunteers for 6 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 16
Study: 34715388

Group type: COMPARATOR
Intervention: Fascia iliaca compartment block (FICB)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pericapsular nerve group block (PENG)
Number of subjects: 52
Study: 34133739

Group type: EXPERIMENTAL
Intervention: Library members incubated in the presence of lead (promotes nonenzymatic cleavage of RNA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Library members incubated in the absence of lead
Number of subjects: 0
Study: 32627890

Group type: EXPERIMENTAL
Intervention: PFO+ breathing air
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PFO+ breathing 16% O2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PFO+ breathing 14% O2
Number of subjects: 30

Group type: COMPARATOR
Intervention: PFO- breathing air
Number of subjects: 30

Group type: COMPARATOR
Intervention: PFO- breathing 16% O2
Number of subjects: 30

Group type: COMPARATOR
Intervention: PFO- breathing 14% O2
Number of subjects: 30

Group type: COMPARATOR
Intervention: PFO+ and PFO- at all levels of hypoxia
Number of subjects: 30
Study: 33517908

Group type: EXPERIMENTAL
Intervention: Increased Less-Healthy (2 healthier, 6 less-healthy)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Increased Healthier (6 healthier, 2 less-healthy)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Equal (2 healthier, 2 less-healthy)
Number of subjects: 417
Study: 32401385

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole 60 mg, once daily before breakfast for 8 weeks
Number of subjects: 232

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg, once daily before breakfast for 8 weeks
Number of subjects: 232
Study: 34896296

Group type: EXPERIMENTAL
Intervention: Healthy for Two/Healthy for You (H42/H4U) health coaching program
Number of subjects: 380

Group type: COMPARATOR
Intervention: Usual prenatal care
Number of subjects: 380
Study: 33055188

Group type: EXPERIMENTAL
Intervention: High-dose eplerenone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33764085

Group type: EXPERIMENTAL
Intervention: Mothers sharing personal good news
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Fathers sharing personal good news
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Perceived partner responsiveness
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Mothers sharing about the child
Number of subjects: 141
Study: 35000939

Group type: EXPERIMENTAL
Intervention: Soft Core Obturators (n = 40)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: GuttaCore Pink Obturators (n = 40)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Positive Control (nonobturated, n = 3)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Negative Control (nonobturated, n = 3)
Number of subjects: 86
Study: 34880156

Group type: EXPERIMENTAL
Intervention: High-dose pitavastatin (4 mg/d)
Number of subjects: 2040

Group type: COMPARATOR
Intervention: Low-dose pitavastatin (1 mg/d)
Number of subjects: 2040
Study: 32074302

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repetitive leg squat exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined activity (WBVT + exercise)
Number of subjects: 0
Study: 34449285

Group type: EXPERIMENTAL
Intervention: Active portable high-efficiency particulate air cleaners
Number of subjects: 116

Group type: COMPARATOR
Intervention: Sham portable high-efficiency particulate air cleaners
Number of subjects: 116
Study: 34218931

Group type: EXPERIMENTAL
Intervention: Question prompt list intervention
Number of subjects: 446

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 446
Study: 32685540

Group type: EXPERIMENTAL
Intervention: Oxford Happiness Inventory (OHI)
Number of subjects: 500
Study: 34121344

Group type: EXPERIMENTAL
Intervention: High-dose biologics
Number of subjects: 5352

Group type: EXPERIMENTAL
Intervention: Biologic-switch
Number of subjects: 5352

Group type: COMPARATOR
Intervention: No-change group
Number of subjects: 5352
Study: 34642026

Group type: EXPERIMENTAL
Intervention: CP/ganitumab (18 mg/kg q3w)
Number of subjects: 170

Group type: COMPARATOR
Intervention: CP/placebo
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: CP/ganitumab
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Ganitumab response
Number of subjects: 170
Study: 33278625

Group type: EXPERIMENTAL
Intervention: Oral ivermectin (12 mg once daily for 5 days)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Oral ivermectin + doxycycline (12 mg ivermectin single dose and 200 mg doxycycline on day 1, followed by 100 mg every 12 h for the next 4 days)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 72
Study: 33571035

Group type: EXPERIMENTAL
Intervention: Oncologist-delivered FCR intervention
Number of subjects: 61
Study: 34602110

Group type: EXPERIMENTAL
Intervention: Fluoxetine or Sertraline treatment for 6 weeks
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sertraline treatment
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: SSRIs (Fluoxetine or Sertraline)
Number of subjects: 200
Study: 34172394

Group type: EXPERIMENTAL
Intervention: Bempedoic acid 180 mg once daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 32074597

Group type: EXPERIMENTAL
Intervention: Patient-Centered Placement Matching (PCPM) guidelines
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Matched aftercare
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Overmatched patients
Number of subjects: 250
Study: 35699705

Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg twice daily; n = 300)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo (n = 200)
Number of subjects: 500
Study: 33032795

Group type: EXPERIMENTAL
Intervention: Self-regulation programme (4-week duration, including one 20-30 min face-to-face education session and 15-20 min telephone follow-ups twice per week)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine outpatient care
Number of subjects: 82
Study: 35737078

Group type: EXPERIMENTAL
Intervention: IncoBoNT‐A 1:2.5 dilution (12 units)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: IncoBoNT‐A 1:5 dilution (6 units)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: IncoBoNT‐A 1:7.5 dilution (4 units)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: IncoBoNT‐A (all concentrations)
Number of subjects: 15
Study: 32534967

Group type: EXPERIMENTAL
Intervention: Hybrid clinical-radiomics model
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Clinical model
Number of subjects: 187
Study: 36151281

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative technique (ART)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conventional restorative techniques
Number of subjects: 11

Group type: COMPARATOR
Intervention: Direct restorative materials
Number of subjects: 11
Study: 33787192

Group type: EXPERIMENTAL
Intervention: Zingiber officinale (Tablet Vomigone 500 mg II tds) and Echinacea (Tablet Rucoldup I tds) for seven days in addition to standard treatment (Hydroxychloroquine)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard treatment (Hydroxychloroquine)
Number of subjects: 100
Study: 34919861

Group type: EXPERIMENTAL
Intervention: WASH intervention (hygiene infrastructure improvements and hygiene promotion)
Number of subjects: 17457

Group type: COMPARATOR
Intervention: Control (delayed WASH intervention)
Number of subjects: 17457

Group type: EXPERIMENTAL
Intervention: WASH intervention
Number of subjects: 17457

Group type: COMPARATOR
Intervention: Control
Number of subjects: 17457
Study: 32063220

Group type: EXPERIMENTAL
Intervention: Retraining group (n = 340) underwent testing of PD knowledge and skills at 1, 3, 6, 12, 18, 24, 30, and 36 months after PD start.
Number of subjects: 671

Group type: COMPARATOR
Intervention: Control group (n = 331) treated according to center routines.
Number of subjects: 671
Study: 34325539

Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 40
Study: 33594643

Group type: EXPERIMENTAL
Intervention: Garvan Fracture Risk Calculator
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: POL-RISK algorithm
Number of subjects: 389

Group type: COMPARATOR
Intervention: Thresholds at 8% and 13%
Number of subjects: 389
Study: 32068531

Group type: EXPERIMENTAL
Intervention: Functional brace
Number of subjects: 540

Group type: COMPARATOR
Intervention: Plaster cast
Number of subjects: 540
Study: 34378863

Group type: EXPERIMENTAL
Intervention: High-dose ergocalciferol (double dosage from K/DOQI guidelines) for 8 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional-dose ergocalciferol (standard dosage according to K/DOQI guidelines) for 8 weeks
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: High-dose ergocalciferol (for subgroup with serum 25[OH]D <20 ng/ml)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional-dose ergocalciferol (for subgroup with serum 25[OH]D <20 ng/ml)
Number of subjects: 70
Study: 33908233

Group type: EXPERIMENTAL
Intervention: Physiotherapy, stabilometric trainings, neuropsychological tasks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Intense physical activity with cyclic exercises, biomechanotherapy
Number of subjects: 52
Study: 32450709

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide (H2O2) clusters at concentrations of 1.0 mM to 9.8 M
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: X-ray irradiation of nitroxyl radical solutions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UVB irradiation at 12000 μW/cm2 for 2 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Addition of K3[Fe(CN)6] or FeCl3 to the reaction mixture
Number of subjects: 0
Study: 34996424

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral therapy (ICBT) for two menstrual cycles
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 92
Study: 36403542

Group type: EXPERIMENTAL
Intervention: Cream with nanoparticles containing vitamin E
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cream without nanoparticles or vitamin E (Control 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cream with nanoparticles without vitamin E (Control 2)
Number of subjects: 40
Study: 32902766

Group type: EXPERIMENTAL
Intervention: Micro-hybride resin-based composite (RBC)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Resin modified glass ionomer cement (RMGIC)
Number of subjects: 33
Study: 35028688

Group type: EXPERIMENTAL
Intervention: Vaccinium fruit supplements
Number of subjects: 20
Study: 35063965

Group type: EXPERIMENTAL
Intervention: venetoclax + azacitidine
Number of subjects: 64

Group type: COMPARATOR
Intervention: azacitidine
Number of subjects: 64
Study: 34342251

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) and Mixed Reality (MR) psychotherapies
Number of subjects: 0
Study: 32072792

Group type: EXPERIMENTAL
Intervention: Lumbar stabilization exercise protocol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stretching exercise protocol
Number of subjects: 20
Study: 36460535

Group type: EXPERIMENTAL
Intervention: FD MVA-BN vaccine (3 lots)
Number of subjects: 1129
Study: 33650407

Group type: EXPERIMENTAL
Intervention: Aviron Rapid® + standard symptomatic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo + standard symptomatic therapy
Number of subjects: 0
Study: 32810147

Group type: EXPERIMENTAL
Intervention: Couples' UBL intervention
Number of subjects: 6770

Group type: EXPERIMENTAL
Intervention: Women's UBL intervention
Number of subjects: 6770

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 6770
Study: 36269054

Group type: EXPERIMENTAL
Intervention: Breastfeeding Counseling (5244)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Usual education plus nursing intervention not related to breastfeeding
Number of subjects: 166